However, cancer cells and immune cells from the tumor stroma, especially activated CD8 + T cells, share metabolic dependencies, making it difficult to obtain combinatory effects with drugs targeting metabolic processes and immune checkpoint blockade. The gene discussed is CD8A; the disease is cancer.